5'-GalNAc C3 Phosphoramidite
Oligonucleotide Conjugation & Delivery Ligands
Resumen del producto
Vista rápida
- Familia de productos
- Oligonucleotide Conjugation & Delivery Ligands
- FM
- C62H88N5O17P
- PM
- 1206.4
- Pureza
- >98%
5'-GalNAc C3 Phosphoramidite is a conjugate building block for installing an N-acetylgalactosamine ("GalNAc") ligand on an oligonucleotide. Its C3-linker scaffold carries a trimethoxytrityl (TMT)-protected hydroxymethyl group and a (2-cyanoethyl N,N-diisopropyl)phosphoramidite. Key identifiers include CAS 2437303-51-8, molecular formula C62H88N5O17P, and molecular weight 1206.4 (PubChem CID 170903051).
The phosphoramidite installs GalNAc at the oligonucleotide 5'-terminus. Glen Research identifies TMT, not DMT, as the protecting group for this product line and demonstrates consecutive GalNAc-amidite additions after detritylation. GalNAc binds the asialoglycoprotein receptor (ASGPR), a lectin on the surface of hepatocytes.
Sinónimos
5'-GalNAc-C3 phosphoramidite; N-acetylgalactosamine C3-linker amidite
Identidad y especificaciones
| Catalog No. | CH67005 |
| CAS No. | 2437303-51-8 |
| Molecular Formula | C62H88N5O17P |
| Molecular Weight | 1206.4 |
| PubChem CID | 170903051 |
| InChIKey | CBVYXTMIYQCOPE-KDYLSCEUSA-N |
| Purity | >98% |
Condiciones de almacenamiento
-20 +/- 5 C
Atributos técnicos
- Ligand
- N-Acetylgalactosamine (GalNAc)
- Linker
- C3
- Coupling group
- Phosphoramidite
- Oligonucleotide position
- 5'-Terminal modification
- Packaging
- 250 mg; 50 µmol; 100 µmol; Custom packaging on request
- Physical form
- white to light-yellow powder
Contexto de aplicación
- 5'-GalNAc conjugation: installs an N-acetylgalactosamine ligand on a C3 linker at the oligonucleotide 5'-terminus.
- Consecutive GalNAc additions: the TMT-protected hydroxymethyl group supports another GalNAc-amidite addition after detritylation.
- ASGPR ligand: GalNAc binds the asialoglycoprotein receptor (ASGPR), a lectin on the surface of hepatocytes.
Recursos técnicos relacionados
administración dirigida a hepatocitos
ligandos GalNAc, grupos reactivos de conjugación de oligos, conjugados lipídicos y enlazadores para administración dirigida al hígado.
GalNAc vs conjugación lipídica
Comparar GalNAc multivalente dirigido a receptor y conjugación lipídica dependiente de estructura como estrategias distintas.
Fuentes públicas
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency in mice
Nucleic Acids Research, 2014
Product-family technical context
- Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits RNAi-mediated gene silencing
Journal of the American Chemical Society, 2014
Product-family technical context
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
ACS Chemical Biology, 2015
Product-family technical context
- Comparative Characterization of Hepatic Distribution and mRNA Reduction of Antisense Oligonucleotides Conjugated with Triantennary N-Acetyl Galactosamine and Lipophilic Ligands
Journal of Pharmacology and Experimental Therapeutics, 2016
Product-family technical context
- Compuesto de PubChem 170903051
PubChem · CID 170903051
Preguntas frecuentes
What does this GalNAc phosphoramidite do?
It installs an N-acetylgalactosamine (GalNAc) ligand on a C3 linker at the oligonucleotide 5'-terminus. The scaffold carries a trimethoxytrityl (TMT)-protected hydroxymethyl group, which can be detritylated before another GalNAc-amidite addition.
What does GalNAc bind?
GalNAc binds the asialoglycoprotein receptor (ASGPR), a lectin on the surface of hepatocytes.
Productos similares
¿Necesita ayuda para seleccionar materiales?
CHEMOS puede revisar adecuación del producto, estructura objetivo, preguntas de ruta, expectativas analíticas y necesidades de suministro del proyecto.